MicroRNA‑124: an emerging therapeutic target in central nervous system disorders
Experimental Brain Research · 2023-05 · 241 (5) · 1215-1226
DOI: 10.1007/s00221-022-06524-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Experimental Brain Research, online erschienen am 24.03.2023. Verfasst von Wen-Hao Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Chinese PLA Medical School/Chinese PLA General Hospital, Beijing, 100095, China. Hauptthemen laut MEDLINE: MicroRNAs, Central Nervous System Diseases. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: national natural science foundation of china.
Abstract (Originalsprache)
The central nervous system (CNS) consists of neuron and non-neuron cells including neural stem/precursor cells (NSPCs), neuroblasts, glia cells (mainly astrocyte, oligodendroglia and microglia), which thereby form a precise and complicated network and exert diverse functions through interactions of numerous bioactive ingredients. MicroRNAs (miRNAs), with small size approximately ~ 21nt and as well-documented post-transcriptional key regulators of gene expression, are a cluster of evolutionarily conserved endogenous non-coding RNAs. More than 2000 different miRNAs has been discovered till now. MicroRNA-124(miR-124), the most brain-rich microRNA, has been validated to possess important functions in the central nervous system, including neural stem cell proliferation and differentiation, cell fate determination, neuron migration, synapse plasticity and cognition, cell apoptosis etc. According to recent studies, herein, we provide a review of this conversant miR-124 to further understand the potential functions and therapeutic and clinical value in brain diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Chinese PLA Medical School/Chinese PLA General Hospital, Beijing, 100095, China.
- Department of Pediatrics, The 4th Hospital of Hebei Medical University, Shijiazhuang, 050010, China.
- Department of Pediatrics, Chinese PLA Medical School/Chinese PLA General Hospital, Beijing, 100095, China. liujingbj2021@163.com.
- Department of Neonatology, Maternal and Child Health Hospital of Chaoyang District, Chaoyang District, Beijing, 100020, China. liujingbj2021@163.com.
Förderung
- national natural science foundation of china
Zitieren
APA
Zhang, W. H., Jiang, L., Li, M., & Liu, J. (2023). MicroRNA‑124: an emerging therapeutic target in central nervous system disorders. Experimental Brain Research, 241(5), 1215-1226. https://doi.org/10.1007/s00221-022-06524-2
Vancouver
Zhang WH, Jiang L, Li M, Liu J. MicroRNA‑124: an emerging therapeutic target in central nervous system disorders. Experimental Brain Research. 2023;241(5):1215-1226. doi:10.1007/s00221-022-06524-2
BibTeX
@article{Zhang2023,
author = {Zhang, Wen-Hao and Jiang, Lian and Li, Mei and Liu, Jing},
title = {MicroRNA‑124: an emerging therapeutic target in central nervous system disorders},
journal = {Experimental Brain Research},
year = {2023},
volume = {241},
number = {5},
pages = {1215--1226},
doi = {10.1007/s00221-022-06524-2}
}
EUVIMED